End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.3
CNY
|
-2.54%
|
|
-6.12%
|
-41.62%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,615
|
1,071
|
906.3
|
2,101
|
1,773
|
1,623
|
Enterprise Value (EV)
1 |
1,649
|
1,040
|
869.8
|
2,044
|
1,713
|
1,591
|
P/E ratio
|
-2.61
x
|
34.7
x
|
-59.5
x
|
-79.6
x
|
119
x
|
-46.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.63
x
|
11.1
x
|
8.35
x
|
16.7
x
|
10.5
x
|
7.79
x
|
EV / Revenue
|
0.65
x
|
10.7
x
|
8.01
x
|
16.2
x
|
10.2
x
|
7.64
x
|
EV / EBITDA
|
-3.63
x
|
-255
x
|
-53.1
x
|
-123
x
|
-41.2
x
|
-33.5
x
|
EV / FCF
|
5.11
x
|
36.5
x
|
-50.9
x
|
61.8
x
|
-10.6
x
|
-22.6
x
|
FCF Yield
|
19.6%
|
2.74%
|
-1.97%
|
1.62%
|
-9.47%
|
-4.42%
|
Price to Book
|
64.1
x
|
19.3
x
|
27.3
x
|
268
x
|
46.1
x
|
33.9
x
|
Nbr of stocks (in thousands)
|
411,948
|
411,948
|
411,948
|
411,948
|
436,648
|
411,948
|
Reference price
2 |
3.920
|
2.600
|
2.200
|
5.100
|
4.060
|
3.940
|
Announcement Date
|
4/28/19
|
4/27/20
|
4/29/21
|
3/20/22
|
3/19/23
|
3/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,547
|
96.84
|
108.6
|
126
|
168.5
|
208.2
|
EBITDA
1 |
-453.8
|
-4.075
|
-16.37
|
-16.65
|
-41.6
|
-47.48
|
EBIT
1 |
-464.5
|
-11.85
|
-24.79
|
-20.84
|
-45.48
|
-51.44
|
Operating Margin
|
-18.24%
|
-12.24%
|
-22.84%
|
-16.54%
|
-26.99%
|
-24.7%
|
Earnings before Tax (EBT)
1 |
-622
|
29.29
|
-13.73
|
-24.87
|
14.67
|
-33.66
|
Net income
1 |
-618.6
|
30.96
|
-15.29
|
-26.41
|
14.07
|
-34.95
|
Net margin
|
-24.29%
|
31.97%
|
-14.08%
|
-20.96%
|
8.35%
|
-16.78%
|
EPS
2 |
-1.500
|
0.0750
|
-0.0370
|
-0.0641
|
0.0340
|
-0.0840
|
Free Cash Flow
1 |
322.6
|
28.49
|
-17.09
|
33.09
|
-162.1
|
-70.28
|
FCF margin
|
12.67%
|
29.42%
|
-15.74%
|
26.27%
|
-96.21%
|
-33.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
92.03%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/28/19
|
4/27/20
|
4/29/21
|
3/20/22
|
3/19/23
|
3/17/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
353
|
Net margin
|
-
|
EPS
2 |
3.429
|
Dividend per Share
|
-
|
Announcement Date
|
4/27/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
34.1
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
30.9
|
36.5
|
57.3
|
59.8
|
32.1
|
Leverage (Debt/EBITDA)
|
-0.075
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
323
|
28.5
|
-17.1
|
33.1
|
-162
|
-70.3
|
ROE (net income / shareholders' equity)
|
-183%
|
75.7%
|
-36.7%
|
-133%
|
64.5%
|
-69.1%
|
ROA (Net income/ Total Assets)
|
-53%
|
-2.17%
|
-4.16%
|
-3.51%
|
-9.47%
|
-14.6%
|
Assets
1 |
1,167
|
-1,426
|
367.3
|
751.8
|
-148.5
|
239.4
|
Book Value Per Share
2 |
0.0600
|
0.1300
|
0.0800
|
0.0200
|
0.0900
|
0.1200
|
Cash Flow per Share
2 |
0.0900
|
0.2200
|
0.2500
|
0.2500
|
0.1600
|
0.0800
|
Capex
1 |
1.93
|
0.13
|
1.77
|
0.11
|
0.19
|
10.8
|
Capex / Sales
|
0.08%
|
0.14%
|
1.63%
|
0.09%
|
0.12%
|
5.21%
|
Announcement Date
|
4/28/19
|
4/27/20
|
4/29/21
|
3/20/22
|
3/19/23
|
3/17/24
|
|
1st Jan change
|
Capi.
|
---|
| -41.62% | 135M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|